Vitamin D-related Genes, Serum Vitamin D Concentrations and Prostate Cancer Risk

Overview

Journal Carcinogenesis

Specialty Oncology

Date 2009 Mar 4

PMID 19255064

Citations 84

Authors

Jiyoung Ahn

Demetrius Albanes

Sonja I Berndt

Ulrike Peters

Nilanjan Chatterjee

Neal D Freedman

Christian C Abnet

Wen-Yi Huang

Adam S Kibel

E David Crawford

Stephanie J Weinstein

Stephen J Chanock

Arthur Schatzkin

Richard B Hayes

Affiliations

Soon will be listed here.

Abstract

We systematically investigated the association of 48 SNPS in four vitamin D metabolizing genes [CYP27A1, GC, CYP27B1 and CYP24A1] with serum 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)(2)D] levels and the association of these SNPS and an additional 164 SNPS in eight downstream mediators of vitamin D signaling [VDR, RXRA, RXRB, PPAR, NCOA1, NCOA2, NCOA3 and SMAD3] with prostate cancer risk in the 749 incident prostate cancer cases and 781 controls of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 25(OH)D (all cases and controls) and 1,25(OH)(2)D (a subset of 150 controls) levels were measured by radioimmunoassay and SNP data were genotyped as part of a genome-wide scan. Among investigated SNPS, only four tag SNPS in GC, the major serum 25(OH)D carrier, were associated with 25(OH)D levels; no SNPS were associated with 1,25(OH)(2)D levels. None of the 212 SNPS examined were associated with cancer risk overall. Among men in the lowest tertile of serum 25(OH)D (<48.9 nmol/l), however, prostate cancer risk was related to tag SNPS in or near the 3' untranslated region (UTR) of VDR, with the strongest association for rs11574143 [odds ratio (95% confidence interval) for risk allele carriers versus wild-type: 2.49 (1.51-4.11), P = 0.0007]; the genotype associations were null among men in tertile 2 and tertile 3. Results from the most comprehensive evaluation of serum vitamin D and its related genes to date suggest that tag SNPS in the 3' UTR of VDR may be associated with risk of prostate cancer in men with low vitamin D status.

Citing Articles

The Role of Vitamin D Metabolism Genes and Their Genomic Background in Shaping Cyclosporine A Dosage Parameters after Kidney Transplantation.

Kotowska K, Wojciuk B, Sienko J, Bogacz A, Stukan I, Drozdzal S J Clin Med. 2024; 13(16).

PMID: 39201108 PMC: 11355102. DOI: 10.3390/jcm13164966.

Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men.

McGrowder D, Tulloch-Reid M, Coard K, McCaw-Binns A, Ferguson T, Aiken W Cancer Control. 2022; 29:10732748221131225.

PMID: 36180132 PMC: 9527998. DOI: 10.1177/10732748221131225.

Assessment of Specific Tumoral Markers, Inflammatory Status, and Vitamin D Metabolism before and after the First Chemotherapy Cycle in Patients with Lung Cancer.

Crintea A, Drugan C, Constantin A, Lupan I, Fekete Z, Silaghi C Biology (Basel). 2022; 11(7).

PMID: 36101414 PMC: 9312139. DOI: 10.3390/biology11071033.

Association Between Vitamin D Binding Protein Gene Polymorphism (rs7041), Vitamin D Receptor, and 25-Hydroxyvitamin D Serum Levels With Prostate Cancer in Kurdish Population in West of Iran.

Amiri M, Elieh Ali Komi D, Vaisi-Raygani A, Kiani A, Moradi M, Aliyari M Pathol Oncol Res. 2022; 28:1610246.

PMID: 36017197 PMC: 9395586. DOI: 10.3389/pore.2022.1610246.

Tipping the Balance: Vitamin D Inadequacy in Children Impacts the Major Gut Bacterial Phyla.

Singh P, Rawat A, Saadaoui M, Elhag D, Tomei S, Elanbari M Biomedicines. 2022; 10(2).

PMID: 35203487 PMC: 8869474. DOI: 10.3390/biomedicines10020278.

References

Hollis B . Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol. 1997; 282:174-86. DOI: 10.1016/s0076-6879(97)82106-4. View

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

Hayes R, Sigurdson A, Moore L, Peters U, Huang W, Pinsky P . Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res. 2005; 592(1-2):147-54. DOI: 10.1016/j.mrfmmm.2005.06.013. View

Carlson C, Eberle M, Rieder M, Yi Q, Kruglyak L, Nickerson D . Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2003; 74(1):106-20. PMC: 1181897. DOI: 10.1086/381000. View

Kliewer S, Umesono K, Noonan D, HEYMAN R, Evans R . Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992; 358(6389):771-4. PMC: 6159883. DOI: 10.1038/358771a0. View

Decker C, Parker R . Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol. 1995; 7(3):386-92. DOI: 10.1016/0955-0674(95)80094-8. View

John E, Schwartz G, Koo J, van den Berg D, Ingles S . Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005; 65(12):5470-9. DOI: 10.1158/0008-5472.CAN-04-3134. View

Deeb K, Trump D, Johnson C . Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7(9):684-700. DOI: 10.1038/nrc2196. View

Verbeek W, Gombart A, Shiohara M, Campbell M, Koeffler H . Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem Biophys Res Commun. 1997; 238(1):77-80. DOI: 10.1006/bbrc.1997.7239. View

10.

Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K . A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997; 12(6):915-21. DOI: 10.1359/jbmr.1997.12.6.915. View

11.

Nomura A, STEMMERMANN G, Lee J, Kolonel L, Chen T, Turner A . Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control. 1998; 9(4):425-32. DOI: 10.1023/a:1008875819232. View

12.

DeLuca H, Zierold C . Mechanisms and functions of vitamin D. Nutr Rev. 1998; 56(2 Pt 2):S4-10; discussion S 54-75. DOI: 10.1111/j.1753-4887.1998.tb01686.x. View

13.

Faupel-Badger J, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea J . Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev. 2007; 16(12):2784-6. DOI: 10.1158/1055-9965.EPI-07-0672. View

14.

Lake S, Lyon H, Tantisira K, Silverman E, Weiss S, Laird N . Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered. 2003; 55(1):56-65. DOI: 10.1159/000071811. View

15.

Oades G, Dredge K, Kirby R, Colston K . Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int. 2002; 90(6):607-16. DOI: 10.1046/j.1464-410x.2002.02964.x. View

16.

Mocharla H, Butch A, Pappas A, Flick J, Weinstein R, DE TOGNI P . Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res. 1997; 12(5):726-33. DOI: 10.1359/jbmr.1997.12.5.726. View

17.

Li H, Stampfer M, Hollis J, Mucci L, Gaziano J, Hunter D . A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007; 4(3):e103. PMC: 1831738. DOI: 10.1371/journal.pmed.0040103. View

18.

Corder E, Guess H, Hulka B, Friedman G, Sadler M, Vollmer R . Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev. 1993; 2(5):467-72. View

19.

Ma J, Stampfer M, Gann P, Hough H, Giovannucci E, Kelsey K . Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev. 1998; 7(5):385-90. View

20.

BARRETO A, Schwartz G, Woodruff R, Cramer S . 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev. 2000; 9(3):265-70. View